Unknown

Dataset Information

Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.


ABSTRACT:

Background and purpose

Experimental and clinical investigations have revealed that statins can downregulate both acute and chronic inflammatory processes. Whether statins express anti-inflammatory activities in the treatment of Crohn's disease is unknown.

Experimental approach

Ten patients were given 80 mg atorvastatin once daily for 13 weeks and then followed up for 8 weeks after the treatment. The anti-inflammatory effects of statin were assessed by measuring levels of plasma C-reactive protein (CRP), soluble (s) CD14, tumour necrosis factor (TNF)-alpha, sTNFRI and II, CCL2 and 8 and the mucosal inflammation by faecal calprotectin. Circulating monocytes were subgrouped and their chemokine receptor expression of CCR2 and CX(3)CR1 were analysed.

Key results

In 8 of 10

SUBMITTER: Grip O 

PROVIDER: S-EPMC2597264 | biostudies-literature | 2008 Dec

REPOSITORIES: biostudies-literature